Viela Bio Inc (VIE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 130,065 | 200,851 | 126,898 |
| Marketable Securities | 237,622 | 113,945 | N/A |
| Receivables | 5,385 | 30,000 | 12,000 |
| TOTAL | $389,299 | $351,038 | $139,354 |
| Non-Current Assets | |||
| PPE Net | 2,786 | 1,499 | 473 |
| Investments And Advances | 10,792 | 31,415 | 0 |
| Intangibles | 18,680 | 0 | 0 |
| Other Non-Current Assets | 1,700 | 102 | 0 |
| TOTAL | $33,958 | $33,016 | $473 |
| Total Assets | $423,257 | $384,054 | $139,827 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 5,570 | 7,459 | 1,142 |
| Accrued Expenses | 16,217 | 9,192 | 2,769 |
| Other current liabilities | 24,258 | 12,892 | 12,054 |
| TOTAL | $46,045 | $29,543 | $15,965 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 1,384 | 0 | 0 |
| TOTAL | $1,384 | $N/A | $N/A |
| Total Liabilities | $47,429 | $29,543 | $15,965 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 54,950 | 50,991 | N/A |
| Common Shares | 55 | 51 | N/A |
| Retained earnings | -427,367 | -276,699 | -190,270 |
| Other shareholders' equity | 79 | 5 | 0 |
| TOTAL | $375,828 | $354,511 | $123,862 |
| Total Liabilities And Equity | $423,257 | $384,054 | $139,827 |